title: Is allogeneic transplant for solid tumors still alive?
authors.affiliation: Medical Oncology Unit, AO Ospedale di Circolo, Department of Oncology, Busto Arsizio, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Bregni
authors.affiliation: EBMT Clinical Trial Office, Hôpital Saint Antoine, Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Badoglio
authors.affiliation: Medical Oncology Unit, IRCCS Policlinico San Matteo, Department of Oncology, Pavia, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Pedrazzoli
authors.affiliation: Hematology Unit, Ospedale Cremona, Cremona, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Lanza
mesh_terms: D000328:Adult; D000368:Aged; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007167:Immunotherapy; D008875:Middle Aged; D009369:Neoplasms / Q000628:therapy*; D011795:Surveys and Questionnaires; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D055815:Young Adult